Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00658450
Other study ID # 2006/HD11/4748U
Secondary ID
Status Completed
Phase N/A
First received April 10, 2008
Last updated December 5, 2012
Start date February 2008
Est. completion date October 2010

Study information

Verified date December 2012
Source Makerere University
Contact n/a
Is FDA regulated No
Health authority Uganda: Research Ethics CommitteeUganda: National Council for Science and Technology
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether computerised cognitive rehabilitation training improves cognition in children who have had cerebral malaria.


Description:

Cerebral malaria affects several children in sub-Saharan Africa leaving some survivors with cognitive problems especially in attention and memory. There are currently no tested interventions for such deficits resulting from infectious diseases like malaria or other causes. Providing such interventions will go a long way in helping these children achieve their full potential.


Recruitment information / eligibility

Status Completed
Enrollment 123
Est. completion date October 2010
Est. primary completion date October 2010
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 5 Years to 15 Years
Eligibility CM group Inclusion Criteria:

- aged five to 15 years, presenting with asexual forms of P. falciparum malaria on a peripheral blood smear, unarousable coma (not able to localize a painful stimulus) and no other cause for coma (normal CSF).

CM group Exclusion Criteria:

- history of or present meningitis, encephalitis, prior CM, sickle cell disease (SCD), HIV infection, epilepsy, multiple seizures, developmental delay and history of hospitalization for malnutrition.

Healthy control group Inclusion Criteria:

- aged five to 15 years with no other illness at present, within two years of the CM child (for CM children aged 5 and 6 years, the HC's age wont go below 5 and for CM children aged 14 and 15, the HC's age wont go above 15 years).

Healthy control group Exclusion Criteria:

- history of or present bacterial meningitis, encephalitis, CM, SCD, HIV infection, history of hospitalization for malnutrition and any chronic illness for which the patient is currently taking medication.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Cognitive rehabilitation training
A computerised cognitive training package where children will be required to complete several cognitive tasks. The aim is to strengthen the different cognitive processes during these tasks which in turn may lead to improve cognitive processes. Children will complete these tasks in 16 session for 8 weeks.

Locations

Country Name City State
Uganda Mulago hospital Acute Care Unit and the Cerebral Malaria Project Kampala

Sponsors (2)

Lead Sponsor Collaborator
Makerere University Karolinska Institutet

Country where clinical trial is conducted

Uganda, 

References & Publications (2)

Bangirana P, Idro R, John CC, Boivin MJ. Rehabilitation for cognitive impairments after cerebral malaria in African children: strategies and limitations. Trop Med Int Health. 2006 Sep;11(9):1341-9. Review. — View Citation

Boivin MJ, Bangirana P, Byarugaba J, Opoka RO, Idro R, Jurek AM, John CC. Cognitive impairment after cerebral malaria in children: a prospective study. Pediatrics. 2007 Feb;119(2):e360-6. Epub 2007 Jan 15. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Improvement in attention scores 6 months No
Secondary Improvement in memory, reasoning, planning, behaviour and academic achievement 6 months No
See also
  Status Clinical Trial Phase
Completed NCT01388842 - Evaluation of the Efficacy and Safety of Inhaled Nitric Oxide as Adjunctive Treatment for Cerebral Malaria in Children Phase 2
Completed NCT00292942 - Study of the Safety of Intravenous Artesunate Phase 1
Completed NCT03300648 - Treating Brain Swelling in Pediatric Cerebral Malaria Phase 3
Recruiting NCT05478720 - DON in Pediatric Cerebral Malaria Phase 1/Phase 2
Completed NCT00292929 - Study of the Safety of Intravenous Artesunate Phase 1